Oryzon Genomics Sa Stock Performance

Oryzon Genomics Relative Risk vs. Return Landscape

If you would invest  361.00  in Oryzon Genomics SA on November 11, 2025 and sell it today you would lose (1.00) from holding Oryzon Genomics SA or give up 0.28% of portfolio value over 90 days. Oryzon Genomics SA is currently producing 0.0035% returns and takes up 1.2635% volatility of returns over 90 trading days. Put another way, 11% of traded pink sheets are less volatile than Oryzon, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.Assuming the 90 days horizon Oryzon Genomics is expected to generate 21.83 times less return on investment than the market. In addition to that, the company is 1.57 times more volatile than its market benchmark. It trades about 0.0 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.09 per unit of volatility.

Oryzon Genomics Target Price Odds to finish over Current Price

Assuming the 90 days horizon Oryzon Genomics has a beta of 0.13. This indicates as returns on the market go up, Oryzon Genomics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Oryzon Genomics SA will be expected to be much smaller as well. Additionally Oryzon Genomics SA has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.

Predictive Modules for Oryzon Genomics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Oryzon Genomics SA. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 2.34 3.60 4.86 Details

Intrinsic Valuation Low Real High 2.28 3.54 4.80 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Oryzon Genomics. Your research has to be compared to or analyzed against Oryzon Genomics' peers to derive any actionable benefits. When done correctly, Oryzon Genomics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Oryzon Genomics SA.

Oryzon Genomics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Oryzon Genomics is not an exception. The market had few large corrections towards the Oryzon Genomics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Oryzon Genomics SA, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Oryzon Genomics within the framework of very fundamental risk indicators.

Oryzon Genomics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Oryzon Genomics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Oryzon Genomics SA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Oryzon Genomics Fundamentals Growth

When running Oryzon Genomics' price analysis, check to measure Oryzon Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oryzon Genomics is operating at the current time. Most of Oryzon Genomics' value examination focuses on studying past and present price action to predict the probability of Oryzon Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oryzon Genomics' price. Additionally, you may evaluate how the addition of Oryzon Genomics to your portfolios can decrease your overall portfolio volatility.